Ariane Nouko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ariane Nouko has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Fabrice Zobel Lekeumo Cheuyem
Department of Public Health, Faculty of Medicine and Biomedical Sciences, The University of Yaounde 1, Yaounde, Cameroon
15 shared publications - Chabeja Achangwa
Department of Public Health, Faculty of Medical Sciences, University of West Indies, Bridgetown, Barbados
8 shared publications - Edwige Omona Guissana
Department of Family Health, Ministry of Public Health, Yaoundé, Cameroon
7 shared publications - Rick Tchamani
Community Research Academy & Consulting, Douala, Cameroon
7 shared publications - Lionel Berthold Keubou Boukeng
Direction for the Fight against Diseases, Epidemics and Pandemics, Ministry of Public Health, Yaounde, Cameroon
6 shared publications - Adidja Amani
Department of Public Health, Faculty of Medicine and Biomedical Sciences, The University of Yaounde I
5 shared publications
Latest Publications
- Open Access
Human immunodeficiency virus and tuberculosis coinfection prevalence and treatment outcomes in Cameroon: a systematic review and meta-analysis
Background: Human immunodeficiency virus (HIV) and tuberculosis (TB) form one of the deadliest syndemics, and sub-Saharan Africa bears over 80% of HIV-associated TB deaths. In Cameroon, evidence on HIV/TB coinfection remains unsynthesized across regions and populations, obscuring the national burden. Hence, we estimated the prevalence of HIV/TB coinfection and treatment outcomes in Cameroon. Methods: Following PRISMA 2020 (PROSPERO: CRD420261399169), we searched PubMed, Scopus, Embase, Web of Science, Cochrane Library, African Journals Online, and grey literature for English- and French-language studies conducted in Cameroon. Reports were independently screened, their data extracted, and their methodology appraised using Joanna Briggs Institute tools. Random-effects models pooled prevalence, treatment outcomes, and adjusted odds ratios. Heterogeneity was assessed with I ². Results: Seventy studies (1995–2023) were included, 87.1% at low risk of bias. Pooled HIV prevalence among TB patients was 29.2% (95% CI: 26.3–32.3; 67 studies; n=57,169; I ² = 97.8%), with no significant evidence of publication bias. Prevalence was higher from 2007 onwards (29.9%; 62 studies; n=55,358) than before (20.5%; 5 studies; n=1,811). It was highest in the North-West (41.9%; 7 studies; n=6,324) versus Littoral (25.0%; 15 studies; n=10,419) and West (23.8%; 6 studies; n=4,206); and in extrapulmonary TB (42.3%; 3 studies; n=371) versus mixed forms (37.7%; 21 studies; n=37,239) and pulmonary TB (23.9%; 37 studies; n=16,096) (all p <0.05). Among coinfected patients, pooled treatment success was 75.9% (95% CI: 70.4–80.8; 8 studies; n=4,230), mortality 21.1% (95% CI: 11.9–34.7; 10 studies; n=4,403), loss to follow-up 7.7% (95% CI: 4.3–13.3; 5 studies; n=3,103), and treatment failure 0.3% (95% CI: 0.1–1.5; 6 studies; n=3,520). Lack of antiretroviral therapy (ART) increased the odds of unfavorable outcomes (AOR = 1.90; 95% CI: 1.15–3.12; 2 studies). Conclusions: Approximately three in ten TB patients in Cameroon are coinfected with HIV, with marked regional and clinical variation. Treatment success remains below national targets. Strengthening TB-HIV service integration, routine HIV testing, and timely ART initiation and continuation is essential to reduce the HIV-associated TB morbidity and mortality in the country.
Open AccessHuman immunodeficiency virus and tuberculosis coinfection prevalence and treatment outcomes in Cameroon: a systematic review and meta-analysis
Background: Human immunodeficiency virus (HIV) and tuberculosis (TB) form one of the deadliest syndemics, and sub-Saharan Africa bears over 80% of HIV-associated TB deaths. In Cameroon, evidence on HIV/TB coinfection remains unsynthesized across regions and populations, obscuring the national burden. Hence, we estimated the prevalence of HIV/TB coinfection and treatment outcomes in Cameroon. Methods: Following PRISMA 2020 (PROSPERO: CRD420261399169), we searched PubMed, Scopus, Embase, Web of Science, Cochrane Library, African Journals Online, and grey literature for English- and French-language studies conducted in Cameroon. Reports were independently screened, their data extracted, and their methodology appraised using Joanna Briggs Institute tools. Random-effects models pooled prevalence, treatment outcomes, and adjusted odds ratios. Heterogeneity was assessed with I ². Results: Seventy studies (1995–2023) were included, 87.1% at low risk of bias. Pooled HIV prevalence among TB patients was 29.2% (95% CI: 26.3–32.3; 67 studies; n=57,169; I ² = 97.8%), with no significant evidence of publication bias. Prevalence was higher from 2007 onwards (29.9%; 62 studies; n=55,358) than before (20.5%; 5 studies; n=1,811). It was highest in the North-West (41.9%; 7 studies; n=6,324) versus Littoral (25.0%; 15 studies; n=10,419) and West (23.8%; 6 studies; n=4,206); and in extrapulmonary TB (42.3%; 3 studies; n=371) versus mixed forms (37.7%; 21 studies; n=37,239) and pulmonary TB (23.9%; 37 studies; n=16,096) (all p <0.05). Among coinfected patients, pooled treatment success was 75.9% (95% CI: 70.4–80.8; 8 studies; n=4,230), mortality 21.1% (95% CI: 11.9–34.7; 10 studies; n=4,403), loss to follow-up 7.7% (95% CI: 4.3–13.3; 5 studies; n=3,103), and treatment failure 0.3% (95% CI: 0.1–1.5; 6 studies; n=3,520). Lack of antiretroviral therapy (ART) increased the odds of unfavorable outcomes (AOR = 1.90; 95% CI: 1.15–3.12; 2 studies). Conclusions: Approximately three in ten TB patients in Cameroon are coinfected with HIV, with marked regional and clinical variation. Treatment success remains below national targets. Strengthening TB-HIV service integration, routine HIV testing, and timely ART initiation and continuation is essential to reduce the HIV-associated TB morbidity and mortality in the country.
- Open Access
- 16 October 2026
- Published by Springer Nature in BMC Research Notes
Vaccine uptake patterns for COVID-19 and cholera among healthcare workers: a cross-sectional study in Yaoundé-Cameroon
- 16 October 2026
- Published by Springer Nature in BMC Research Notes
Open AccessVaccine uptake patterns for COVID-19 and cholera among healthcare workers: a cross-sectional study in Yaoundé-Cameroon
- Open Access
- 27 July 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Humanization of care: a geospatial analysis of key indicators of quality and safety of health care and service in the Centre region, Cameroon
Integrating the principles of humanized care into healthcare systems is critical to promoting optimal well-being. In a context of limited resources, improv
- 27 July 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Open AccessHumanization of care: a geospatial analysis of key indicators of quality and safety of health care and service in the Centre region, Cameroon
Integrating the principles of humanized care into healthcare systems is critical to promoting optimal well-being. In a context of limited resources, improv
- Open Access
Vaccination status and associated factors among healthcare workers providing primary care: a cross-sectional study in Yaoundé, Cameroon
Background: Healthcare workers (HCWs) are at increased risk of exposure to vaccine-preventable diseases, including hepatitis B, tuberculosis (TB), and tetanus, due to their occupational environment. Despite the availability of safe and effective vaccines, vaccination coverage among HCWs remains suboptimal in many low- and middle-income countries. This study aimed to determine the vaccination coverage for hepatitis B, tuberculosis, and tetanus among HCWs in district hospitals in Yaoundé, Cameroon, and to identify factors associated with incomplete vaccination. Methods: A cross-sectional analytical study was conducted from January to June 2024 across all seven district hospitals in Yaoundé. A total of 406 HCWs were enrolled using a structured, self-administered questionnaire. Incomplete vaccination status was defined as nit having received three doses for hepatitis B, at least two doses for TB, and at least three doses for tetanus. Data were analyzed using R Statistics version 4.3.3. Bivariate and multivariate logistic regression models were used to identify predictors of incomplete vaccination, with statistical significance set at p < 0.05. Results: Most of participants were female (75.6%) and aged 30-44 years (65.5%). Full vaccination coverage was 36.2% for hepatitis B, 15.8% for tuberculosis, and 53.4% for tetanus. Unvaccinated proportions were 43.1% for hepatitis B, 0.5% for tuberculosis, and 17.2% for tetanus. Multivariate analysis revealed that HCWs aged 55-66 years were significantly less likely to be incompletely vaccinated against hepatitis B compared to those aged 19-29 years (aOR = 0.07; 95% CI: 0.01-0.39; p = 0.004). Nurses and laboratory technicians were more likely to be incompletely vaccinated than doctors (aOR = 7.06; 95% CI: 3.82-13.6; p < 0.001 and aOR = 3.78; 95% CI: 1.73-8.52; p = 0.001, respectively). Longer professional experience was protective against incomplete vaccination for all three vaccines ( p < 0.05). The main barriers to vaccination included high cost, doubts about the need for vaccination, and concerns about side effects. Conclusions: Vaccination coverage for hepatitis B, tuberculosis, and tetanus among HCWs in Yaoundé remains suboptimal, particularly for hepatitis B. Addressing financial barriers, improving access to vaccines, and implementing targeted educational interventions are essential to enhance vaccine uptake and protect both HCWs and their patients from preventable occupational infections.
Open AccessVaccination status and associated factors among healthcare workers providing primary care: a cross-sectional study in Yaoundé, Cameroon
Background: Healthcare workers (HCWs) are at increased risk of exposure to vaccine-preventable diseases, including hepatitis B, tuberculosis (TB), and tetanus, due to their occupational environment. Despite the availability of safe and effective vaccines, vaccination coverage among HCWs remains suboptimal in many low- and middle-income countries. This study aimed to determine the vaccination coverage for hepatitis B, tuberculosis, and tetanus among HCWs in district hospitals in Yaoundé, Cameroon, and to identify factors associated with incomplete vaccination. Methods: A cross-sectional analytical study was conducted from January to June 2024 across all seven district hospitals in Yaoundé. A total of 406 HCWs were enrolled using a structured, self-administered questionnaire. Incomplete vaccination status was defined as nit having received three doses for hepatitis B, at least two doses for TB, and at least three doses for tetanus. Data were analyzed using R Statistics version 4.3.3. Bivariate and multivariate logistic regression models were used to identify predictors of incomplete vaccination, with statistical significance set at p < 0.05. Results: Most of participants were female (75.6%) and aged 30-44 years (65.5%). Full vaccination coverage was 36.2% for hepatitis B, 15.8% for tuberculosis, and 53.4% for tetanus. Unvaccinated proportions were 43.1% for hepatitis B, 0.5% for tuberculosis, and 17.2% for tetanus. Multivariate analysis revealed that HCWs aged 55-66 years were significantly less likely to be incompletely vaccinated against hepatitis B compared to those aged 19-29 years (aOR = 0.07; 95% CI: 0.01-0.39; p = 0.004). Nurses and laboratory technicians were more likely to be incompletely vaccinated than doctors (aOR = 7.06; 95% CI: 3.82-13.6; p < 0.001 and aOR = 3.78; 95% CI: 1.73-8.52; p = 0.001, respectively). Longer professional experience was protective against incomplete vaccination for all three vaccines ( p < 0.05). The main barriers to vaccination included high cost, doubts about the need for vaccination, and concerns about side effects. Conclusions: Vaccination coverage for hepatitis B, tuberculosis, and tetanus among HCWs in Yaoundé remains suboptimal, particularly for hepatitis B. Addressing financial barriers, improving access to vaccines, and implementing targeted educational interventions are essential to enhance vaccine uptake and protect both HCWs and their patients from preventable occupational infections.
- Open Access
- 1 July 2026
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 50 (1)
Mpox severity and mortality in the DRC: a systematic review and meta-analysis (1970–2024)
Background: Mpox, caused by the Mpox virus, is a zoonotic disease historically endemic in Central and West Africa. Despite the Democratic Republic of Congo (DRC) carrying the highest Mpox burden, the literature lacks comprehensive data on long-term trends and geographic disparities inMpox% disease severity and mortality, highlighting a significant research gap. Understanding severity and mortality trends is critical for global control efforts. Methods: This systematic review and meta-analysis followed PRISMA guidelines to synthesize evidence on Mpox severity and mortality in the DRC from 1970 to 2024. We searched PubMed, ScienceDirect, Scopus, Web of Science. Random-effects models addressed high heterogeneity, and subgroup analyses examined temporal trends, regional differences, and healthcare settings. Meta-regression explored sources of heterogeneity for both severity and case fatality rate, adjusting for study year, region, and setting. Results: We included a total of 19 study reports. The pooled severity rate among 3,280 confirmed cases was 39.47% (95% confidence interval [CI] 29.11–50.86). Case fatality rates (CFRs) were 1.70% (95% CI 0.72–3.95) among 3152 suspected cases and 2.46% (95% CI 0.65–8.85) for 2239 confirmed cases. Meta-regression revealed that study year, region and setting were significant sources of heterogeneity of case fatality rates among confirmed mpox cases. Conclusion: Mpox continues to impose a substantial burden in the DRC, with a high severity and moderate mortality rates. Targeted interventions, including vaccination in high-risk areas, community education, and healthcare system strengthening are warranted.
- 1 July 2026
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 50 (1)
Open AccessMpox severity and mortality in the DRC: a systematic review and meta-analysis (1970–2024)
Background: Mpox, caused by the Mpox virus, is a zoonotic disease historically endemic in Central and West Africa. Despite the Democratic Republic of Congo (DRC) carrying the highest Mpox burden, the literature lacks comprehensive data on long-term trends and geographic disparities inMpox% disease severity and mortality, highlighting a significant research gap. Understanding severity and mortality trends is critical for global control efforts. Methods: This systematic review and meta-analysis followed PRISMA guidelines to synthesize evidence on Mpox severity and mortality in the DRC from 1970 to 2024. We searched PubMed, ScienceDirect, Scopus, Web of Science. Random-effects models addressed high heterogeneity, and subgroup analyses examined temporal trends, regional differences, and healthcare settings. Meta-regression explored sources of heterogeneity for both severity and case fatality rate, adjusting for study year, region, and setting. Results: We included a total of 19 study reports. The pooled severity rate among 3,280 confirmed cases was 39.47% (95% confidence interval [CI] 29.11–50.86). Case fatality rates (CFRs) were 1.70% (95% CI 0.72–3.95) among 3152 suspected cases and 2.46% (95% CI 0.65–8.85) for 2239 confirmed cases. Meta-regression revealed that study year, region and setting were significant sources of heterogeneity of case fatality rates among confirmed mpox cases. Conclusion: Mpox continues to impose a substantial burden in the DRC, with a high severity and moderate mortality rates. Targeted interventions, including vaccination in high-risk areas, community education, and healthcare system strengthening are warranted.
- Open Access
- 28 May 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Mpox knowledge and perception in Africa: a systematic review and meta-analysis
Mpox, a zoonotic disease long endemic in Africa, has gained renewed global attention due to recent outbreaks. Effective control of the virus relies on public adherence to preventive measures, which is largely shaped by the population's knowledge and perceptions. This systematic review and meta-analysis aimed to determine the pooled prevalence of good knowledge and positive perceptions of mpox in Africa and to identify associated factors. Following PRISMA 2020 guidelines, a comprehensive search was conducted in PubMed, Web of Science, Scopus Embase, CINAHL, ScienceDirect, African Journals Online. Studies conducted in African countries that assessed knowledge and/or perception of mpox were included. Pooled prevalence with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and meta-regression were performed to explore heterogeneity. The analysis included 38 studies with 23,648 participants from 15 African countries. The pooled prevalence of good mpox knowledge was 43.12% (95% CI: 34.38-52.32), indicating significant gaps in awareness. Knowledge varied substantially across subgroups. By participant type, teachers had the highest knowledge prevalence (89.43%), followed by healthcare workers (50.54%), while the general population had markedly lower knowledge (14.88%). Regionally, Southern Africa had the highest knowledge prevalence (77.92%), whereas Central Africa had the lowest (19.20%). At the country level, South Africa (77.92%) and Kenya (68.31%) recorded the highest levels, while Libya (5.34%) and Somalia (9.68%) had the lowest. The pooled prevalence of a positive perception or attitude toward mpox was 54.22% (95% CI: 44.94-63.21). Pregnant women (81.43%) and healthcare workers (57.37%) reported the most positive perceptions, whereas community health workers showed the least (10.19%). Positive perception was highest in Northern Africa (63.02%) and lowest in Central Africa (7.27%). Individual levels of mpox knowledge and perception were associated with age, gender, education and profession. This study reveals that overall knowledge of mpox across Africa is insufficient, and that positive perceptions are only moderate, with considerable disparities across different populations and regions. The findings underscore an urgent need for targeted educational campaigns, enhanced training for healthcare workers, and context-specific communication strategies to boost awareness, improve attitudes, and strengthen continent-wide outbreak control and preparedness.
- 28 May 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessMpox knowledge and perception in Africa: a systematic review and meta-analysis
Mpox, a zoonotic disease long endemic in Africa, has gained renewed global attention due to recent outbreaks. Effective control of the virus relies on public adherence to preventive measures, which is largely shaped by the population's knowledge and perceptions. This systematic review and meta-analysis aimed to determine the pooled prevalence of good knowledge and positive perceptions of mpox in Africa and to identify associated factors. Following PRISMA 2020 guidelines, a comprehensive search was conducted in PubMed, Web of Science, Scopus Embase, CINAHL, ScienceDirect, African Journals Online. Studies conducted in African countries that assessed knowledge and/or perception of mpox were included. Pooled prevalence with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and meta-regression were performed to explore heterogeneity. The analysis included 38 studies with 23,648 participants from 15 African countries. The pooled prevalence of good mpox knowledge was 43.12% (95% CI: 34.38-52.32), indicating significant gaps in awareness. Knowledge varied substantially across subgroups. By participant type, teachers had the highest knowledge prevalence (89.43%), followed by healthcare workers (50.54%), while the general population had markedly lower knowledge (14.88%). Regionally, Southern Africa had the highest knowledge prevalence (77.92%), whereas Central Africa had the lowest (19.20%). At the country level, South Africa (77.92%) and Kenya (68.31%) recorded the highest levels, while Libya (5.34%) and Somalia (9.68%) had the lowest. The pooled prevalence of a positive perception or attitude toward mpox was 54.22% (95% CI: 44.94-63.21). Pregnant women (81.43%) and healthcare workers (57.37%) reported the most positive perceptions, whereas community health workers showed the least (10.19%). Positive perception was highest in Northern Africa (63.02%) and lowest in Central Africa (7.27%). Individual levels of mpox knowledge and perception were associated with age, gender, education and profession. This study reveals that overall knowledge of mpox across Africa is insufficient, and that positive perceptions are only moderate, with considerable disparities across different populations and regions. The findings underscore an urgent need for targeted educational campaigns, enhanced training for healthcare workers, and context-specific communication strategies to boost awareness, improve attitudes, and strengthen continent-wide outbreak control and preparedness.
- Open Access
- 20 May 2026
- Published by Scifiniti Publishing in Evidence Synthesis in Healthcare Connect
- Vol. 1 (1) , 1-10
Mpox Clinical and Epidemiological Patterns in the Central African Republic: a Systematic Review and Meta-analysis
This study included 40 years evidences (1984-2024) describing the Mpox epidemiology, vaccination and clinical pattern in the Central African Republic (CAR), informing targeted control strategies for this re-emerging threat. This systematic review and meta-analysis followed the PRISMA guidelines. The searches was conducted on PubMed, Scopus, ScienceDirect, Web of science, Embase, Cochrane Library, and AJOL. The random effect model was used to pooled estimates with R version 4.5.2. A p-value <0.05 was considered statistically significant. We included a total of seven studies conducted from 1984 to 2023. Our analysis revealed a pooled severity rate of 60.92% (95% confidence interval (CI): 47.54-72.83), peaking at 77.27% (95%CI: 55.64-90.21) in Health Region 6. Before the global Mpox outbreak in 2022, the case fatality rate (CFR) for confirmed cases was 10.71% (95% CI: 4.52-23.28). Eastern Health Regions had a higher CFR of 10.81% (95% CI: 4.03-25.93), while Western Regions reported 0.00% (95% CI: 0.00-100.00). For suspected cases, the CFR was 12.13% (95% CI: 5.59-24.34), slightly declining to 9.09% (95% CI: 0.23-41.28) post-2022. This geographic disparity remained, with Eastern Regions at 10.17% (95% CI: 4.64-20.84) and Western Regions at 5.26% (95% CI: 0.74-29.39). Vaccination uptake in CAR was 20.00% (95% CI: 10.33-35.17). The clinical profile included fever (91.1% (95%CI: 42.9-99.3)), rash (85.5% (95%CI: 75.7-91.8)), and lymphadenopathy (57.0% (95%CI: 34.3-77.1)). The CAR is one of the most affected countries in Africa by Mpox. This was characterized by high severity, elevated mortality, and suboptimal vaccine coverage, particularly in eastern regions. In order to prevent future outbreak in the country, these findings point the necessity to improve vaccination distribution, give priority to high (risk populations, and improve the surveillance systems with genomic sequencing capacity. In context-specific interventions, including community education on prevention measures and healthcare worker training will help reducing the mpox-related morbidity and mortality.
- 20 May 2026
- Published by Scifiniti Publishing in Evidence Synthesis in Healthcare Connect
- Vol. 1 (1) , 1-10
Open AccessMpox Clinical and Epidemiological Patterns in the Central African Republic: a Systematic Review and Meta-analysis
This study included 40 years evidences (1984-2024) describing the Mpox epidemiology, vaccination and clinical pattern in the Central African Republic (CAR), informing targeted control strategies for this re-emerging threat. This systematic review and meta-analysis followed the PRISMA guidelines. The searches was conducted on PubMed, Scopus, ScienceDirect, Web of science, Embase, Cochrane Library, and AJOL. The random effect model was used to pooled estimates with R version 4.5.2. A p-value <0.05 was considered statistically significant. We included a total of seven studies conducted from 1984 to 2023. Our analysis revealed a pooled severity rate of 60.92% (95% confidence interval (CI): 47.54-72.83), peaking at 77.27% (95%CI: 55.64-90.21) in Health Region 6. Before the global Mpox outbreak in 2022, the case fatality rate (CFR) for confirmed cases was 10.71% (95% CI: 4.52-23.28). Eastern Health Regions had a higher CFR of 10.81% (95% CI: 4.03-25.93), while Western Regions reported 0.00% (95% CI: 0.00-100.00). For suspected cases, the CFR was 12.13% (95% CI: 5.59-24.34), slightly declining to 9.09% (95% CI: 0.23-41.28) post-2022. This geographic disparity remained, with Eastern Regions at 10.17% (95% CI: 4.64-20.84) and Western Regions at 5.26% (95% CI: 0.74-29.39). Vaccination uptake in CAR was 20.00% (95% CI: 10.33-35.17). The clinical profile included fever (91.1% (95%CI: 42.9-99.3)), rash (85.5% (95%CI: 75.7-91.8)), and lymphadenopathy (57.0% (95%CI: 34.3-77.1)). The CAR is one of the most affected countries in Africa by Mpox. This was characterized by high severity, elevated mortality, and suboptimal vaccine coverage, particularly in eastern regions. In order to prevent future outbreak in the country, these findings point the necessity to improve vaccination distribution, give priority to high (risk populations, and improve the surveillance systems with genomic sequencing capacity. In context-specific interventions, including community education on prevention measures and healthcare worker training will help reducing the mpox-related morbidity and mortality.
- Open Access
Vaccine uptake patterns for COVID-19 and cholera among healthcare workers: a cross-sectional study in Yaoundé-Cameroon
Objective: Healthcare workers (HCWs) are at increased risk of COVID-19 infection and play a critical role in influencing public vaccine acceptance. This study aimed to assess vaccination coverage and identify the determinants of vaccine uptake among healthcare workers in Cameroon, in order to inform targeted strategies to strengthen immunization programs and improve epidemic preparedness. Results: Among 406 participants (75.6% female, 65.5% aged 30-44 years, 61.3% nurses), 42.4% were fully vaccinated against COVID-19, while only 4.7% had completed the cholera vaccine series. Coverage varied across districts, with Biyem-Assi (53.0%) and Odza (46.0%) recording the highest COVID-19 uptake, and Nkolndongo (11.5%) leading for cholera vaccination. Independent predictors of COVID-19 uptake included being a nurse (aOR = 3.96; 95% CI: 2.07-7.81; p = 0.001) and laboratory technician professions (aOR = 8.00; 95% CI: 1.38-69.8; p =0.032). For cholera vaccination, working in internal medicine wards (aOR=11.2; 95% CI: 1.04-120; p = 0.046) and being a nurse (aOR = 1.54; p = 0.001) emerged as significant predictors. Although 62.8% of HCWs perceived their work environment as high-risk, knowledge of recommended vaccines was limited, with only 18.7% aware of cholera vaccination recommendations. Strengthening vaccine education, improving accessibility, and reducing financial barriers could enhance vaccine acceptance among HCWs. These findings provide important insights for designing targeted immunization strategies in Cameroon and similar contexts.
Open AccessVaccine uptake patterns for COVID-19 and cholera among healthcare workers: a cross-sectional study in Yaoundé-Cameroon
Objective: Healthcare workers (HCWs) are at increased risk of COVID-19 infection and play a critical role in influencing public vaccine acceptance. This study aimed to assess vaccination coverage and identify the determinants of vaccine uptake among healthcare workers in Cameroon, in order to inform targeted strategies to strengthen immunization programs and improve epidemic preparedness. Results: Among 406 participants (75.6% female, 65.5% aged 30-44 years, 61.3% nurses), 42.4% were fully vaccinated against COVID-19, while only 4.7% had completed the cholera vaccine series. Coverage varied across districts, with Biyem-Assi (53.0%) and Odza (46.0%) recording the highest COVID-19 uptake, and Nkolndongo (11.5%) leading for cholera vaccination. Independent predictors of COVID-19 uptake included being a nurse (aOR = 3.96; 95% CI: 2.07-7.81; p = 0.001) and laboratory technician professions (aOR = 8.00; 95% CI: 1.38-69.8; p =0.032). For cholera vaccination, working in internal medicine wards (aOR=11.2; 95% CI: 1.04-120; p = 0.046) and being a nurse (aOR = 1.54; p = 0.001) emerged as significant predictors. Although 62.8% of HCWs perceived their work environment as high-risk, knowledge of recommended vaccines was limited, with only 18.7% aware of cholera vaccination recommendations. Strengthening vaccine education, improving accessibility, and reducing financial barriers could enhance vaccine acceptance among HCWs. These findings provide important insights for designing targeted immunization strategies in Cameroon and similar contexts.
- Open Access
Mpox knowledge and perception in Africa: a systematic review and meta-analysis
Background: Mpox, a zoonotic disease long endemic in Africa, has gained renewed global attention due to recent outbreaks. Effective control of the virus relies on public adherence to preventive measures, which is largely influenced by the population’s knowledge and perception. This systematic review and meta-analysis aimed to determine the pooled prevalence of good knowledge and positive perception toward mpox in Africa and to identify associated factors. Methods: Following PRISMA guidelines, a comprehensive search was conducted across multiple relevant databases and grey literature sources. Studies conducted in African countries that assessed knowledge and/or perception of mpox were included. Pooled prevalences with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and meta-regression were performed to explore heterogeneity. Results: The analysis incorporated 38 studies with 23,648 participants from 15 African countries. The pooled prevalence of good mpox knowledge was 43.12% (95% CI: 34.38–52.32), indicating significant gaps in awareness. Knowledge levels varied substantially across subgroups. By participant type, teachers exhibited the highest knowledge (89.43%), followed by medical students (56.02%) and healthcare workers (51.39%), while the general population demonstrated markedly lower knowledge (14.88%). Geographically, Southern Africa had the highest knowledge prevalence (77.92%), whereas Central Africa had the lowest (19.20%). At the country level, South Africa (77.92%) and Kenya (68.31%) recorded the highest levels, while Libya (5.34%) and Somalia (9.68%) had the lowest. The pooled prevalence of a positive perception or attitude toward mpox was 54.22% (95% CI: 44.94–63.21). Pregnant women (81.43%) and healthcare workers (60.32%) reported the most positive perceptions, whereas community health workers showed the least (10.19%). Positive perception was highest in Northern Africa (63.02%) and lowest in Central Africa (7.27%). Individual levels of mpox knowledge and perception were significantly associated with several sociodemographic and non-sociodemographic factors. Conclusions: This study reveals that overall knowledge of mpox across Africa is insufficient, and positive perception is only moderate, with considerable disparities across different populations and regions. The findings underscore an urgent need for targeted educational campaigns, enhanced training for healthcare workers, and context-specific communication strategies to boost awareness, improve attitudes, and strengthen continent-wide outbreak control and preparedness.
Open AccessMpox knowledge and perception in Africa: a systematic review and meta-analysis
Background: Mpox, a zoonotic disease long endemic in Africa, has gained renewed global attention due to recent outbreaks. Effective control of the virus relies on public adherence to preventive measures, which is largely influenced by the population’s knowledge and perception. This systematic review and meta-analysis aimed to determine the pooled prevalence of good knowledge and positive perception toward mpox in Africa and to identify associated factors. Methods: Following PRISMA guidelines, a comprehensive search was conducted across multiple relevant databases and grey literature sources. Studies conducted in African countries that assessed knowledge and/or perception of mpox were included. Pooled prevalences with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and meta-regression were performed to explore heterogeneity. Results: The analysis incorporated 38 studies with 23,648 participants from 15 African countries. The pooled prevalence of good mpox knowledge was 43.12% (95% CI: 34.38–52.32), indicating significant gaps in awareness. Knowledge levels varied substantially across subgroups. By participant type, teachers exhibited the highest knowledge (89.43%), followed by medical students (56.02%) and healthcare workers (51.39%), while the general population demonstrated markedly lower knowledge (14.88%). Geographically, Southern Africa had the highest knowledge prevalence (77.92%), whereas Central Africa had the lowest (19.20%). At the country level, South Africa (77.92%) and Kenya (68.31%) recorded the highest levels, while Libya (5.34%) and Somalia (9.68%) had the lowest. The pooled prevalence of a positive perception or attitude toward mpox was 54.22% (95% CI: 44.94–63.21). Pregnant women (81.43%) and healthcare workers (60.32%) reported the most positive perceptions, whereas community health workers showed the least (10.19%). Positive perception was highest in Northern Africa (63.02%) and lowest in Central Africa (7.27%). Individual levels of mpox knowledge and perception were significantly associated with several sociodemographic and non-sociodemographic factors. Conclusions: This study reveals that overall knowledge of mpox across Africa is insufficient, and positive perception is only moderate, with considerable disparities across different populations and regions. The findings underscore an urgent need for targeted educational campaigns, enhanced training for healthcare workers, and context-specific communication strategies to boost awareness, improve attitudes, and strengthen continent-wide outbreak control and preparedness.
- Open Access
Mpox clinical and epidemiological patterns in the Central African Republic: a systematic review and meta-analysis
Background: Mpox remains a critical public health challenge in Central Africa, where endemic circulation of the virulent Clade I virus persists through zoonotic and human-to-human transmission. This systematic review and meta-analysis synthesize 40 years of evidence (1984-2024) to characterize Mpox epidemiology, vaccination gaps and clinical pattern in the Central African Republic (CAR), informing targeted control strategies for this re-emerging threat. Methods: Following PRISMA guidelines, we conducted a comprehensive search of PubMed, Scopus, ScienceDirect, Web of science, Embase, Cochrane Library, and AJOL for studies reporting laboratory-confirmed Mpox cases in CAR. Pooled estimates were calculated using random/fixed-effects models with R Software version 4.4.2 with subgroup analysis conducted for period, region, participants and disease burden. Heterogeneity ( I 2 ) and publication bias (funnel plots, Egger’s and Begg’s tests) were rigorously assessed. The confidence intervals (CIs) were estimated at 95% level of confidence. A p -value ⍰5% was considered statistically significant. Results: Analysis of seven studies (1984-2023) found a pooled severity rate of 60.9% (95%CI: 48.5-77.7), peaking at 77.3% (95%CI: 55.6-90.2) in Health Region 6. Before the global mpox outbreak, the CFR for confirmed cases was 11.54% (95% CI: 6.11-20.71). Eastern Health Regions had a higher CFR of 11.11% (95% CI: 5.08-22.60), while Western Regions reported 0.00% (95% CI: 0.00-100.00). For suspected cases, the CFR was 12.77% (95% CI: 7.39-21.15), slightly declining to 9.09% (95% CI: 0.23-41.28) post-2022. This geographic disparity remained, with Eastern Regions at 10.17% (95% CI: 4.64-20.84) and Western Regions at 5.26% (95% CI: 0.74-29.39). Vaccination uptake in CAR was only 20.00% (95% CI: 10.33-35.17). The clinical profile included fever (91.1% (95%CI: 42.9-99.3)), rash (85.5% (95%CI: 75.7-91.8)), and lymphadenopathy (57.0% (95%CI: 34.3-77.1)). Conclusion: The CAR faces a disproportionate Mpox burden characterized by high severity, elevated mortality, and suboptimal vaccine coverage, particularly in eastern regions. These findings suggest the urgent need for: (1) enhanced surveillance systems with genomic sequencing capacity; (2) prevention of disease lethality through early case detection and appropriate care provision; (3) strengthening vaccine distribution prioritizing high-risk populations; and (4) context-specific interventions, including community education and healthcare worker training, to curb future outbreaks.
Open AccessMpox clinical and epidemiological patterns in the Central African Republic: a systematic review and meta-analysis
Background: Mpox remains a critical public health challenge in Central Africa, where endemic circulation of the virulent Clade I virus persists through zoonotic and human-to-human transmission. This systematic review and meta-analysis synthesize 40 years of evidence (1984-2024) to characterize Mpox epidemiology, vaccination gaps and clinical pattern in the Central African Republic (CAR), informing targeted control strategies for this re-emerging threat. Methods: Following PRISMA guidelines, we conducted a comprehensive search of PubMed, Scopus, ScienceDirect, Web of science, Embase, Cochrane Library, and AJOL for studies reporting laboratory-confirmed Mpox cases in CAR. Pooled estimates were calculated using random/fixed-effects models with R Software version 4.4.2 with subgroup analysis conducted for period, region, participants and disease burden. Heterogeneity ( I 2 ) and publication bias (funnel plots, Egger’s and Begg’s tests) were rigorously assessed. The confidence intervals (CIs) were estimated at 95% level of confidence. A p -value ⍰5% was considered statistically significant. Results: Analysis of seven studies (1984-2023) found a pooled severity rate of 60.9% (95%CI: 48.5-77.7), peaking at 77.3% (95%CI: 55.6-90.2) in Health Region 6. Before the global mpox outbreak, the CFR for confirmed cases was 11.54% (95% CI: 6.11-20.71). Eastern Health Regions had a higher CFR of 11.11% (95% CI: 5.08-22.60), while Western Regions reported 0.00% (95% CI: 0.00-100.00). For suspected cases, the CFR was 12.77% (95% CI: 7.39-21.15), slightly declining to 9.09% (95% CI: 0.23-41.28) post-2022. This geographic disparity remained, with Eastern Regions at 10.17% (95% CI: 4.64-20.84) and Western Regions at 5.26% (95% CI: 0.74-29.39). Vaccination uptake in CAR was only 20.00% (95% CI: 10.33-35.17). The clinical profile included fever (91.1% (95%CI: 42.9-99.3)), rash (85.5% (95%CI: 75.7-91.8)), and lymphadenopathy (57.0% (95%CI: 34.3-77.1)). Conclusion: The CAR faces a disproportionate Mpox burden characterized by high severity, elevated mortality, and suboptimal vaccine coverage, particularly in eastern regions. These findings suggest the urgent need for: (1) enhanced surveillance systems with genomic sequencing capacity; (2) prevention of disease lethality through early case detection and appropriate care provision; (3) strengthening vaccine distribution prioritizing high-risk populations; and (4) context-specific interventions, including community education and healthcare worker training, to curb future outbreaks.